Authors: VANSTOLK R BUDD GT KRESTY R GANAPATHI R ELSON P CHURCH J PIAZZA G FRYER B PROVENCHER K PAMUKCU R HAWK E KELLOFF G STONER G

Citation: R. Vanstolk et al., EFFECT OF SULINDAC SULFONE ON PROLIFERATION, APOPTOSIS, AND POLYPS INA CLINICAL-TRIAL IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS, Gastroenterology, 114(4), 1998, pp. 2881-2881

Authors: VANSTOLK R PROVENCHER K BURKE C CHURCH J PAMUKCU R

Citation: R. Vanstolk et al., SULINDAC SULFONE (FGN-1) IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) - POLYP EFFECT AND TOLERABILITY FROM AN OPEN-LABEL EXTENSIONTRIAL, Gastroenterology, 114(4), 1998, pp. 2882-2882

Authors: ZUCCARO G PROVENCHER K

Citation: G. Zuccaro et K. Provencher, DOES AN OPEN ACCESS SYSTEM PROPERLY UTILIZE ENDOSCOPIC RESOURCES, Gastrointestinal endoscopy, 46(1), 1997, pp. 15-20

Authors: VANSTOLK RU DEYOUNG B CHURCH JM GANAPATHI R PROVENCHER K STONER G HAWK E PAMUKCU R KELLOFF G BUDD GT

Citation: Ru. Vanstolk et al., CLINICOPATHOLOGICAL CORRELATION OF RECTAL ADENOMA REGRESSION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TREATED WITH SULINDAC SULFONE IN A PHASE I II TRIAL/, Gastroenterology, 112(4), 1997, pp. 673-673

Authors: VANSTOLK RU BUDD GT HAYTON W ELSON P PROVENCHER K CHURCH JM GANAPATHI R STONER G HAWK E PAMUKCU R KELLOFF G CHAN K

Citation: Ru. Vanstolk et al., PHASE-I TRIAL OF SULINDAC SULFONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS - OPTIMAL DOSE AND SAFETY, Gastroenterology, 112(4), 1997, pp. 673-673

Authors: ZUCCARO G PROVENCHER K SIVAK MV

Citation: G. Zuccaro et al., OUTCOMES OF UPPER ENDOSCOPY IN AN OPEN REFERRAL SYSTEM - AN EVALUATION OF THE APPROPRIATE USE OF GASTROINTESTINAL ENDOSCOPY DOCUMENT OF THEAMERICAN-SOCIETY-FOR-GASTROINTESTINAL-ENDOSCOPY, Gastrointestinal endoscopy, 39(2), 1993, pp. 264-264